Literature DB >> 7498964

Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats.

R M Touyz1, L Y Deng, E L Schiffrin.   

Abstract

Endothelin-1 elicits vasoconstrictor responses through endothelin subtype A receptors, which are located on vascular smooth muscle cells, and vasodilator responses through endothelin subtype B receptors, which occur predominantly on endothelial cells. Endothelin subtype B receptors also may be present on vascular smooth muscle cells, in which they may mediate vasoconstriction. The aims of this study were to determine the presence of vascular smooth muscle vasoconstrictor endothelin subtype B receptors in mesenteric resistance arteries and to assess whether endothelin subtype B receptor-mediated responses differ between spontaneously hypertensive rats and Wistar-Kyoto rats. Contractile responses to the endothelin subtype B receptor agonist sarafotoxin S6c and endothelin-1 were measured simultaneously with [Ca2+]i in endothelium-denuded mesenteric resistance arteries from adult spontaneously hypertensive rats and Wistar-Kyoto rats. To simulate in vivo conditions matched as closely as possible to in vitro conditions, vessels were mounted in a vessel flow chamber in which intraluminal pressure was maintained at 60 mm Hg. Contraction was determined by video imaging to record lumen diameter, and [Ca2+]i was measured by the fura 2 method. Basal [Ca2+]i was significantly higher (P < .01) in hypertensive (170 +/- 4 nmol/L) compared with normotensive rats (134 +/- nmol/L). The endothelin subtype B receptor agonist sarafotoxin S6c increased [Ca2+]i in a concentration-dependent manner. Sarafotoxin S6c-induced [Ca2+]i and contractile responses were significantly lower in hypertensive compared with normotensive rats. These data demonstrate that endothelin subtype B receptors are present in vascular smooth muscle of small arteries and that endothelin subtype B receptor-mediated vasoconstriction occurs through intracellular calcium signaling pathways.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498964     DOI: 10.1161/01.hyp.26.6.1041

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.

Authors:  P Laurant; A Berthelot
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

2.  Localization and function of ET-1 and ET receptors in small arteries post-myocardial infarction: upregulation of smooth muscle ET(B) receptors that modulate contraction.

Authors:  G A Gray; E J Mickley; D J Webb; P E McEwan
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein.

Authors:  Audrey Claing; Hadia Shbaklo; Mirco Plante; Ghassan Bkaily; Pedro D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats.

Authors:  Minghui Ou; Yiping Dang; Marc Q Mazzuca; Rebecca Basile; Raouf A Khalil
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

5.  Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis.

Authors:  Alicia Rivera; Siok Yuen Kam; Mengfatt Ho; Jose R Romero; Soohee Lee
Journal:  Blood Cells Mol Dis       Date:  2012-10-31       Impact factor: 3.039

6.  Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats.

Authors:  Marc Q Mazzuca; Yiping Dang; Raouf A Khalil
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy.

Authors:  Marc Q Mazzuca; Wei Li; Ossama M Reslan; Peng Yu; Karina M Mata; Raouf A Khalil
Journal:  Hypertension       Date:  2014-06-09       Impact factor: 10.190

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.